Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Editas Medicine (EDIT) Invested Capital (2016 - 2025)

Editas Medicine (EDIT) has disclosed Invested Capital for 11 consecutive years, with $72.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Invested Capital fell 58.71% to $72.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $72.5 million, a 58.71% decrease, with the full-year FY2024 number at $191.7 million, down 45.08% from a year prior.
  • Invested Capital was $72.5 million for Q3 2025 at Editas Medicine, down from $75.9 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $638.0 million in Q1 2021 to a low of $72.5 million in Q3 2025.
  • A 5-year average of $354.3 million and a median of $360.5 million in 2023 define the central range for Invested Capital.
  • Peak YoY movement for Invested Capital: skyrocketed 171.99% in 2021, then crashed 67.3% in 2025.
  • Editas Medicine's Invested Capital stood at $553.6 million in 2021, then crashed by 34.85% to $360.7 million in 2022, then fell by 3.21% to $349.1 million in 2023, then tumbled by 45.08% to $191.7 million in 2024, then crashed by 62.17% to $72.5 million in 2025.
  • Per Business Quant, the three most recent readings for EDIT's Invested Capital are $72.5 million (Q3 2025), $75.9 million (Q2 2025), and $117.0 million (Q1 2025).